Alpha-thalassemia

Last updated: August 05, 2022

Alpha-thalassemia

BIIC

BIIC

Thymus histology
Spleen histology
Lymph node histology
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Blood histology
Blood components
Blood groups and transfusions
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Role of Vitamin K in coagulation
Clot retraction and fibrinolysis
von Hippel-Lindau disease
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Pyruvate kinase deficiency
Hereditary spherocytosis
Beta-thalassemia
Alpha-thalassemia
Iron deficiency anemia
Anemia of chronic disease
Sickle cell disease (NORD)
Erythropoietin
Hemophilia
Vitamin K deficiency
Von Willebrand disease
Sideroblastic anemia
Autoimmune hemolytic anemia
Paroxysmal nocturnal hemoglobinuria
Aplastic anemia
Fanconi anemia
Folate (Vitamin B9) deficiency
Vitamin B12 deficiency
Megaloblastic anemia
Diamond-Blackfan anemia
Lead poisoning
Bernard-Soulier syndrome
Hemolytic-uremic syndrome
Thrombotic thrombocytopenic purpura
Immune thrombocytopenia
Glanzmann's thrombasthenia
Disseminated intravascular coagulation
Heparin-induced thrombocytopenia
Antithrombin III deficiency
Protein C deficiency
Antiphospholipid syndrome
Factor V Leiden
Protein S deficiency
Polycythemia vera (NORD)
Mixed platelet and coagulation disorders: Pathology review
Coagulation disorders: Pathology review
Macrocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Platelet disorders: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Myeloproliferative disorders: Pathology review
Anticoagulants: Heparin
Anticoagulants: Warfarin
Thrombolytics
Hematopoietic medications
Protein synthesis inhibitors: Tetracyclines
DNA synthesis inhibitors: Fluoroquinolones
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
Protein synthesis inhibitors: Aminoglycosides
Yellow fever virus
Dengue virus
Ebola virus
Hantavirus
Salmonella typhi (typhoid fever)
Yersinia pestis (Plague)
Borrelia burgdorferi (Lyme disease)
Rickettsia rickettsii (Rocky Mountain spotted fever) and other Rickettsia species
Coxiella burnetii (Q fever)
Ehrlichia and Anaplasma
Hodgkin lymphoma
Non-Hodgkin lymphoma
Chronic leukemia
Acute leukemia
Myelodysplastic syndromes
Myelofibrosis (NORD)
Essential thrombocythemia (NORD)
Multiple myeloma
Waldenstrom macroglobulinemia
Leukemias: Pathology review
Lymphomas: Pathology review
Plasma cell disorders: Pathology review
Ribonucleotide reductase inhibitors
Topoisomerase inhibitors
Platinum containing medications
Anti-tumor antibiotics
Microtubule inhibitors
DNA alkylating medications
Monoclonal antibodies
Antimetabolites for cancer treatment
HIV and AIDS: Pathology review
HIV (AIDS)
Integrase and entry inhibitors
Protease inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)

Transcript

Watch video only

Alpha-thalassemia is a genetic disorder where there’s a deficiency in production of the alpha globin chains of hemoglobin, which is the oxygen-carrying protein in red blood cells.

Normally, hemoglobin is made up of four globin chains, each bound to a heme group. There are four major types of globin chains- alpha (α), beta (β), gamma (γ), and delta (δ). These four globin chains combine in different ways to give rise different kinds of hemoglobin. First, there’s hemoglobin F (or HbF), where F stands for fetal hemoglobin, and it’s made up of two α-globin and two γ-globin chains. Hemoglobin A (or HbA) is the major form of adult hemoglobin, made up of two α-globin and two β-globin chains. Finally, hemoglobin A2 (or HbA2) amounts for a small fraction of adult hemoglobin in the blood, and it’s made up of two α-globin and two δ-globin chains. Alpha chain synthesis is controlled by four alpha genes, two on each copy of chromosome 16. And alpha thalassemia is caused by mutations in the alpha genes, most commonly a gene deletion. The mutations are inherited in an autosomal recessive pattern, which means that you need mutated genes from both parents to get the disease. If a person has one defective alpha gene, they’re called a silent carrier, because they don’t have symptoms, but can still pass the gene to their children. If a person has two defective alpha genes, the person has alpha thalassemia minor, which causes mild symptoms. This can either be caused by a ‘cis’ deletion, where mutated genes are on the same chromosome; or a ‘trans’ deletion when the mutated genes are on two different chromosomes. Cis-deletion variants are more prevalent in Asian populations, whereas, trans-deletion variants are more prevalent in African populations.

If there are three defective alpha genes, there’s moderate disease, called hemoglobin H, or HbH, disease. This is caused by excess beta chains, which clump together within developing red blood cells to form tetramers (β4), and give rise to a form of hemoglobin called hemoglobin H. HbH molecules cause hypoxia in two ways. First, they damage the red blood cell membrane, resulting in intramedullary hemolysis, or red blood cell breakdown in the bone marrow; or extravascular hemolysis, when red blood cells are destroyed by macrophages in the spleen. Second, HbH has very high affinity for oxygen, and doesn’t release oxygen to the tissues. And a consequence of hypoxia is that it signals the bone marrow, as well as extramedullary tissues like the liver and spleen, to increase production of red blood cells. This may cause the bones that contain bone marrow, as well as the liver and spleen, to enlarge.

Finally, if all four alpha genes are deleted, it results in Hb Bart’s hydrops fetalis. The problem here begins during fetal life, where gamma chains form tetramers in the absence of alpha chains, called Hb Bart’s (γ4). And It has super duper high affinity for oxygen, about 100 times that of normal Hb! So, the tissues get no oxygen, resulting in severe hypoxia. Severe hypoxia leads to high-output cardiac failure and massive hepatosplenomegaly, resulting in edema all over the body, called hydrops fetalis. This condition is incompatible with life, and without treatment, the fetus usually dies in utero, or soon after birth!

Key Takeaways

Alpha-thalassemia is an inherited blood disorder in which there is insufficient production of alpha globin chains of hemoglobin. Hemoglobin is the protein in red blood cells that carries oxygen from the lungs to all parts of the body. Symptoms will vary depending on the extent of the deficiency of the globin chains. Some people with alpha-thalassemia do not have symptoms, while others experience mild to moderate anemia.

Sources

  1. "Robbins and Cotran Pathologic Basis of Disease, Professional Edition E-Book" Elsevier Health Sciences (2014)
  2. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  3. "Alpha and beta thalassemia" PubMed (2009)
  4. "Alpha Thalassemia" NCBI (2021)
  5. "The α-Thalassemias" New England Journal of Medicine (2014)
  6. "Alpha thalassemia" MedlinePlus (2017)